MeSH term
Frequency | Condition_Probility | Aged | 5 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Humans | 22 | 0.0 |
Kallikreins/*biosynthesis | 2 | 33.0 |
Male | 8 | 0.0 |
Middle Aged | 4 | 0.0 |
Prognosis | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Base Sequence | 6 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Kallikreins/*genetics | 8 | 32.0 |
Molecular Sequence Data | 7 | 0.0 |
Prostate-Specific Antigen/*genetics | 4 | 20.0 |
Aged, 80 and over | 3 | 0.0 |
Female | 7 | 0.0 |
*Gene Expression | 2 | 0.0 |
Kallikreins/*biosynthesis/genetics | 2 | 22.0 |
Research Support, Non-U.S. Gov't | 13 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 3 | 0.0 |
DNA | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Animals | 3 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
*Multigene Family | 2 | 0.0 |
Tissue Kallikreins/*genetics | 4 | 33.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Tissue Kallikreins | 4 | 8.0 |
Adult | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Mice | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
